Brand Name
Epinastine
View Brand InformationFDA approval date: September 14, 2016
Classification: Histamine-1 Receptor Inhibitor
Form: Solution
What is Epinastine?
Epinastine HCl ophthalmic solution is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. Epinastine HCl ophthalmic solution is indicated for the prevention of itching associated with allergic conjunctivitis.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment